Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
02/10/1993 | EP0526695A1 Stabilized PVP-I solutions |
02/10/1993 | EP0526666A1 Solid lipid microspheres having a narrow size distribution and method for producing them |
02/10/1993 | EP0526578A1 Composition and method for topical treatment of damaged or diseased tissue |
02/10/1993 | EP0526566A1 Treatment of erectile dysfunction |
02/10/1993 | EP0526540A1 Use of 5-ht 4? receptor antagonists in the treatment of arrythmias and stroke |
02/10/1993 | EP0526481A1 The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations. |
02/10/1993 | EP0493489A4 Film-enrobed unitary-core medicament and the like |
02/10/1993 | EP0445156B1 Agents for treating chronic inflammatory diseases of the intestines |
02/10/1993 | CN1068741A Healthy pack with medicine |
02/10/1993 | CN1068739A Improved oral dosing formulations of dideoxy purine nucleosides |
02/10/1993 | CN1068736A Process for preparing antifungal composition for external application |
02/10/1993 | CN1068735A Stable compositions for parenteral adiministration and thier use |
02/10/1993 | CN1068734A Therapeutic agent |
02/10/1993 | CN1068733A Mouth protection liquid for parodontosis (canned and self-spraying type) |
02/09/1993 | US5185373 Inhibition of thermal degradation of ibuprofen |
02/09/1993 | US5185372 Sealed container of solution of retinol palmitate, boric acid, nonionic surfactant, chelating agent, preservative; adjusted pH; topical treatment of dry eye syndrome |
02/09/1993 | US5185336 Spray drying aqueous solution or suspension |
02/09/1993 | US5185335 N-(4-piperodinyl)(dihydrobenzofuran or dihydro-2h-benzopyran) carboxamide derivatives |
02/09/1993 | US5185159 Pharmaceutical composition based on valproic acid and a process for preparing it |
02/09/1993 | US5185158 Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same |
02/09/1993 | US5185157 Treatment of refractory Eosinophilia-Myalgia Syndrome with L-tryptophan composition |
02/09/1993 | US5185154 Dissolving charged or uncharged phospholipids, depositing on patterned silicon wafer, drying formed film, adding water to form vesicles |
02/09/1993 | US5185153 Agents effecting the lysis of oral bacteria |
02/09/1993 | US5185152 Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye |
02/09/1993 | US5185099 Visco-elastic, isotropic materials based on water, fluorinate sufactants and fluorinated oils, process for their preparation, and their use in various fields, such as optics, pharmacology and electrodynamics |
02/09/1993 | CA1313497C Administrative and dosage from drug active agents, reagents or the like and process for the preparation thereof |
02/06/1993 | CA2075340A1 Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery |
02/04/1993 | WO1993003714A2 Method for treatment of metabolic disorders |
02/04/1993 | WO1993002039A1 Alkyl galactarates, their preparation methods and use |
02/04/1993 | WO1993001841A1 Improvements in antibiotic-containing acrylic beads |
02/04/1993 | WO1993001831A1 Induction of cytotoxic t-lymphocyte responses |
02/04/1993 | WO1993001814A1 Oxicam or oxicam derivatives-containing ophthalmic compositions |
02/04/1993 | WO1993001811A1 Method of preparing a sterile-filterable solution of an active substance |
02/04/1993 | WO1993001809A1 Pharmaceutical formulations comprised of micronised halofantrine |
02/04/1993 | WO1993001807A1 Transdermal delivery device |
02/04/1993 | WO1993001806A1 Encapsulated perfluorocarbons |
02/04/1993 | WO1993001802A1 Composition for the sustained and controlled release of a medicinal peptide-containing substance, and preparation method therefor |
02/04/1993 | WO1993001801A1 Lipid vesicles having n,n-dimethylamide derivatives as their primary lipid |
02/04/1993 | WO1993001800A1 Therapeutic compositions and methods |
02/04/1993 | WO1993001799A1 Process for the manufacture of bioerodible poly(orthoester)s and polyacetals |
02/04/1993 | WO1993001798A1 Preparations comprising a fluorocarbon and a lipophilic/fluorophilic organic compound, and their uses |
02/04/1993 | WO1993001793A1 Liquid deodorant compositions |
02/04/1993 | WO1993001790A1 Dental tray |
02/04/1993 | WO1993001776A1 Device for administering bimakalim transdermally |
02/04/1993 | WO1993001746A1 Electrically conductive gel composition |
02/04/1993 | DE4210165A1 Transdermale therapeutische systeme Transdermal therapeutic systems |
02/04/1993 | DE4125400A1 Verwendung von kollagen zur behandlung von degenerativen gelenkprozessen Use of collagen for the treatment of degenerative joint processes |
02/04/1993 | DE4125332A1 Emulgatorkonzentrat Emulsifying |
02/04/1993 | DE4125255A1 Prostaglandin e (pfeil abwaerts)1(pfeil abwaerts)-formulierung Prostaglandin E (Down Arrow) 1 (down arrow) formulation, |
02/04/1993 | DE4125048A1 Retard pharmaceutical prepn. for periodontitis treatment - contains anti-periodontitis drug esp. metronidazole, in cationic (meth)acrylic] polymer matrix pref. used as film strip |
02/04/1993 | CA2114836A1 Lipid vesicles having n, n-dimethylamide derivatives as their primary lipid |
02/04/1993 | CA2114122A1 Therapeutic compositions and methods |
02/04/1993 | CA2113817A1 A method for treatment of metabolic disorders |
02/04/1993 | CA2113720A1 Induction of cytotoxic t-lymphocyte responses |
02/04/1993 | CA2113542A1 Preparations comprising a fluorocarbon and a lipophilic/fluorophilic organic compound, and their uses |
02/04/1993 | CA2113185A1 The preparation of an active substance solution which can be sterilized by filtration |
02/03/1993 | EP0526301A1 Alkyl galactarates, processes for their preparation and applications thereof |
02/03/1993 | EP0525813A1 Water-soluble composition for sustained-release |
02/03/1993 | EP0525740A1 Stevia extract-containing liquid internal medicine and method of preparing the same |
02/03/1993 | EP0525731A2 Seamless capsule and process for producing the same |
02/03/1993 | EP0525655A1 Formulations useful for vaginal dryness treatment |
02/03/1993 | EP0525475A2 A beta-blocker and carbachol containing antiglaucoma composition |
02/03/1993 | EP0525389A2 Process for preparing mechanically stable, well disintegrating tablets from small active agent containing solid forms |
02/03/1993 | EP0525388A1 Suckable or chewable tablet |
02/03/1993 | EP0525333A1 High amylose-content starches for preparing powdery compositions |
02/03/1993 | EP0525307A1 Stable compositions for parenteral administration and their use |
02/03/1993 | EP0525267A2 Prolonged occlusion treatment system |
02/03/1993 | EP0525199A1 Composition containing ultrafine particles of magnetic metal oxide |
02/03/1993 | EP0525177A1 Unimolecular micelles and method of making the same |
02/03/1993 | EP0525167A1 Sustained drug release through topical application of bioadhesive liposomes. |
02/03/1993 | EP0525163A1 Binding of growth hormone to liposomes. |
02/03/1993 | EP0525154A1 Interaction between bioadhesive liposomes and target sites |
02/03/1993 | EP0525132A1 Binding of recognizing substances to liposomes. |
02/03/1993 | EP0525105A1 Polyisobutylene adhesives for transdermal devices. |
02/03/1993 | EP0525055A1 Improved iontophoretic administration of drugs |
02/03/1993 | EP0525039A1 Method and apparatus for inducing transformations in waxes |
02/03/1993 | EP0524987A1 Eriodictyon drug delivery systems |
02/03/1993 | EP0524981A1 Eriodictyon extract pharmaceutical compositions |
02/03/1993 | EP0346343B1 Anti-viral therapeutic composition |
02/03/1993 | CN1068500A Jetting agent for gynaecology disease curing and its preparing process |
02/03/1993 | CN1068494A Compound |
02/03/1993 | CA2075082A1 Prolonged occlusion treatment system |
02/02/1993 | WO1993002661A1 Use of a tocopherol phosphate or one of its derivatives, for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
02/02/1993 | US5183882 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
02/02/1993 | US5183862 Capped polylactones uses as sustained release drug delivery, dispersants, adhesives, binders |
02/02/1993 | US5183829 Oral liquid compositions of non-steroidal anti-inflammatory drugs |
02/02/1993 | US5183802 Mixed with nontoxic effective amount of adsorption enhancer-ammonium glycyrrhizinate and a carrier; used as nose sprays for treatment of osteoporosis |
02/02/1993 | US5183746 Formulation processes for pharmaceutical compositions of recombinant β- |
02/02/1993 | US5183690 Imparting predetermined release properties to an active agent in a starch matrix by extrusion, under specified conditions of a stream containing starch, active agent and water and recovering |
02/02/1993 | US5183666 Pressing not delayed release of active compound, process for its production and use of polyhydroxybutyric acid for the production of such a pressing |
02/02/1993 | US5183662 Controlled drug release composition |
02/02/1993 | US5183589 Stable emulsions of perfluoropolyethers |
02/02/1993 | CA2114225A1 Use of a tocopherol phosphate or one of its derivatives, for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
02/02/1993 | CA2075005A1 Water-soluble composition for sustained-release |
02/02/1993 | CA1313352C Transdermal drug delivery device with dual permeation enhancers |
01/31/1993 | WO1993002635A1 Foramenous implant |
01/31/1993 | CA2092825A1 Foramenous implant |
01/28/1993 | DE4223282A1 Zubereitung zur stetigen und kontrollierten abgabe von medikamentoesen substanzen und verfahren zu deren herstellung Preparation for continuous and controlled release of medicamentous substances and processes for their preparation |
01/28/1993 | DE4124252A1 Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung Process for the preparation of a sterilized by drug-spoon |
01/27/1993 | EP0524892A1 Method for preparation of an anhydrous solid dispersion |